Tumour-Reactive Plasma Cells in Antitumour Immunity: Current Insights and Future Prospects

JOURNAL ARTICLE published 25 April 2024 in Immunotherapy Advances

Authors: Peng Chen | Yiwei Chu | Ronghua Liu

Establishment of Humanised Xenograft Models as In Vivo Study for Lung Metastasis of Osteosarcoma

JOURNAL ARTICLE published 23 March 2024 in Immunotherapy Advances

Authors: Farhana Khamarudin | Mudiana Muhamad | Mohamad Johari I | Wan Nor I’zzah WMZ | Mardiana Abdul Aziz | Nurul Raudzah Adib Ridzuan | Sharaniza Ab-Rahim

Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodeficiency diseases: a phase 3, open-label study

JOURNAL ARTICLE published 1 January 2024 in Immunotherapy Advances

Authors: Hirokazu Kanegane | Akifumi Endo | Satoshi Okada | Hidenori Ohnishi | Masataka Ishimura | Ryuta Nishikomori | Kohsuke Imai | Shigeaki Nonoyama | Hideki Muramatsu | Taizo Wada | Atsushi Kuga | Ko Sakamoto | Sharon Russo-Schwarzbaum | Liang-Hui Chu | Barbara McCoy | Zhaoyang Li | Leman Yel

Ex vivo comparative immunogenicity assessment (EVCIA) to determine relative immunogenicity in chronic plaque psoriasis in participants receiving Humira® or undergoing repeated switches between Humira® and AVT02

JOURNAL ARTICLE published 1 January 2024 in Immunotherapy Advances

Research funded by Alvotech (GPP 2022)

Authors: Kathleen Richter | Halimu N Haliduola | Jana Schockaert | Aurélie Mazy | Nataliya Reznichenko | Eric Guenzi | Fausto Berti

Cancer vaccines: from an immunology perspective

JOURNAL ARTICLE published 1 January 2024 in Immunotherapy Advances

Research funded by Cancer Research UK (A28334)

Authors: Shania Makker | Charlotte Galley | Clare L Bennett

Harnessing natural killer cell effector function against cancer

JOURNAL ARTICLE published 1 January 2024 in Immunotherapy Advances

Research funded by Medical Research Council (MR/M019829/1) | Cancer Research UK (C42023/A29370)

Authors: Matthew D Blunt | Salim I Khakoo

Strategies to overcome low MHC-I expression in paediatric and adult tumours

JOURNAL ARTICLE published 1 January 2024 in Immunotherapy Advances

Research funded by Lymph@Co (2018-LyCo-002)

Authors: J Guillaume | A Perzolli | M Boes

Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Research funded by Cancer Research UK (C58264/A26593) | Medical Research Council (MR/N001435/1) | Marie Skłodowska-Curie (955321)

Authors: Natalie M Edner | Elisavet Ntavli | Lina Petersone | Chun Jing Wang | Astrid Fabri | Alexandros Kogimtzis | Vitalijs Ovcinnikovs | Ellen M Ross | Frank Heuts | Yassin Elfaki | Luke P Houghton | Toby Talbot | Amna Sheri | Alexandra Pender | David Chao | Lucy S K Walker

Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Research funded by Wellcome Trust (218454/Z/19/Z)

Authors: Andrew Abaasa | Moses Egesa | Emmanuella Driciru | Jan Pieter R Koopman | Ronald Kiyemba | Richard E Sanya | Jacent Nassuuna | Agnes Ssali | Geofrey Kimbugwe | Anne Wajja | Govert J van Dam | Paul L A M Corstjens | Stephen Cose | Janet Seeley | Dorcas Kamuya | Emily L Webb | Maria Yazdanbakhsh | Pontiano Kaleebu | Afzal A Siddiqui | Narcis Kabatereine | Edridah Tukahebwa | Meta Roestenberg | Alison M Elliott

A historical perspective on HLA

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Authors: Walter Bodmer

Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Research funded by Ministry of Education, Sports, and Culture of Japan (16H06295) | Japan Agency for Medical Research and Development (18gm0010005)

Authors: Shimon Sakaguchi | Ryoji Kawakami | Norihisa Mikami

Combination therapies for the optimisation of Bispecific T-cell Engagers in cancer treatment

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Authors: Winston M Zhu | Mark R Middleton

Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Authors: Shuya Kaneko | Fumiaki Sakura | Kay Tanita | Asami Shimbo | Ryusuke Nambu | Masashi Yoshida | Shuichiro Umetsu | Ayano Inui | Chizuru Okada | Miyuki Tsumura | Mamiko Yamada | Hisato Suzuki | Kenjiro Kosaki | Osamu Ohara | Masaki Shimizu | Tomohiro Morio | Satoshi Okada | Hirokazu Kanegane

Correction to: Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Time to treat the climate and nature crisis as one indivisible global health emergency

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Authors: Kamran Abbasi | Parveen Ali | Virginia Barbour | Thomas Benfield | Kirsten Bibbins-Domingo | Stephen Hancocks | Richard Horton | Laurie Laybourn-Langton | Robert Mash | Peush Sahni | Wadeia Mohammad Sharief | Paul Yonga | Chris Zielinski

Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Research funded by Wellcome Trust (225737/Z/22/Z)

Authors: Megan V C Barnes | Anika Mandla | Emma Smith | Maija Maskuniitty | Peter J M Openshaw | Yara-Natalie Abo | Stephanie Ascough | Helen Ashwin | Panisadee Avirutnan | Andrew P Catchpole | Primus Che Chi | Christopher Chiu | Thomas C Darton | Emmanuella Driciru | Dingase Dula | Daniela M Ferreira | Alastair Fraser | Phoebe Garrett | Diane Gbesemete | Stephen Gordon | David L Heymann | Emma Houlder | Euzebiusz Jamrozik | Melissa Kapulu | Enock Kessy | Anna M Overgaard Kildemoes | Jan Pieter Koopman | Helen McShane | Oranich Navanukroh | Faith H Osier | Joshua Osowicki | Vy Pham | Andrew J Pollard | Woraphat Ratta-apha | Sarah E Silk | Saranya Sridhar | Kena A Swanson | Kawsar R Talaat | Ryan S Thwaites | Orly Welch | HIC-Vac meeting contributors

TIGIT-based immunotherapeutics in lung cancer

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Authors: Akshay J Patel | Gary W Middleton

Peripheral blood persistence and expansion of transferred non-genetically modified Natural Killer cells might not be necessary for clinical activity

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Authors: Lucia Silla

Correction to: Immunology of allergen immunotherapy

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Research funded by National Institutes of Health (AI139538,AI169619,AI170715,AI170715,AI165072)

Impact of Fc receptors and host characteristics on myeloid phagocytic response to rituximab-treated 3D-cultured B-cell lymphoma

JOURNAL ARTICLE published 1 January 2023 in Immunotherapy Advances

Authors: Sandra Kleinau